Oxa0h 0002 01
Oxaliplatin Injection, Solution
Product Images NDC 71288-101
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 71288-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Oxa0h 0002 02
Oxa0h 0002 03
Oxa0h 0002 04
The given text contains information regarding the median survival for two types of injections i.e. Oxalpatin injection, USP + SFULY and Oxaliplatin Injection plus natecan. The median survival for the former was 19.4 months while for the latter, it was 178 months. A log-rank test was carried out to compare the two injections. Therefore, the text provides data on the comparative efficacy of two injections used in a medical context.*
Oxa0h 0002 05
NDC 71288-101-10 is a medication called Oxaliplatin and is available as an injection. It is a cytotoxic agent and should only be used intravenously. The medication comes in a 10 mL single-dose vial and should only be used with chloride-containing solutions. The manufacturer is Meitheal Pharmaceuticals, and it was made in India in 2018. Batch details can be printed online.*
Oxa0h 0002 06
Each vial of this medication contains Oxaliplatin, USP 50mg and sterile Water for Injection, USP (10/mL). The package insert should be consulted for dosage and further instructions. This medication is a cytotoxic agent for intravenous use only and is not to be mixed with or added to solutions containing sodium chloride. It should be stored at room temperature between 20°C and 25°C (68°F and 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Unused portions should be discarded, and the package insert should be consulted for storage instructions for further diluted solutions. NDC numbers and manufacturer information are also provided.*
Oxa0h 0002 07
NDC 71288-101-20 is a single-dose injection of Oxaliplatin, a cytotoxic agent for intravenous use only, manufactured by Meitheal Pharmaceuticals. It contains 100mg of Oxaliplatin per 20mL and should not be mixed or added to sodium chloride or chloride-containing solutions. Batch details are available online.*
Oxa0h 0002 08
This seems to be a description of a medication called cARo0sase02 contained in a vial. Each vial contains Oralpltin, USP 100mg and water for injection. The dosage and administration instructions are available in the package insert. It must be stored at 20° to 25°C and should not be frozen. The medication is a cytotoxic agent for intravenous use only. It should not be mixed with sodium chloride-containing solutions and has a sterile aqueous solution that is preservative-free. Further details on its storage are available in the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
